Increasing women's choices in medical abortion: A study of misoprostol 400 μg swallowed immediately or held sublingually following 200 mg mifepristone

By Akın Ayse   Dabash Rasha   Dilbaz Berna   Aktun Hale   Dursun Polat   Kıran Sibel   Aksan Guldeniz   Doğan Bahar   Winikoff Beverly  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 3, 2009-06 ,pp. : 169-175

Informa Healthcare

Access to resources Recommend Favorite

Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaççao

By Boersma Adriana A.   Meyboom-de Jong Betty   Kleiverda Gunilla  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 2, 2011-04 ,pp. : 61-66

Informa Healthcare

Access to resources Recommend Favorite

Experience and Acceptability of Medical Abortion with Mifepristone and Misoprostol Among U.S. Women

By Beckman L.J.   Harvey S.M.  

Women's Health Issues, Vol. 7, Iss. 4, 1997-07 ,pp. : 253-262

Elsevier

Access to resources Recommend Favorite

Home use of two doses of misoprostol after mifepristone for medical abortion: A pilot study in Sweden and France

By Clark W. H.   Hassoun D.   Gemzell-Danielsson K.   Fiala C.   Winikoff B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 3, 2005-09 ,pp. : 184-191

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 112-119

Informa Healthcare

Access to resources Recommend Favorite